Home

slušalica brojati Lijen flipi2 score follicular lymphoma calculator Kružni Fondovi zaslijepljujući

Frontiers | An Immune-Clinical Prognostic Index (ICPI) for Patients With De  Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy
Frontiers | An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy

Enhancement of the Follicular Lymphoma International Prognostic Index  (FLIPI) with lymphopenia (FLIPI-L): a predictor for overall survival and  histologic transformation | Blood Cancer Journal
Enhancement of the Follicular Lymphoma International Prognostic Index (FLIPI) with lymphopenia (FLIPI-L): a predictor for overall survival and histologic transformation | Blood Cancer Journal

Impact of treatment in long-term survival patients with follicular lymphoma:  A Spanish Lymphoma Oncology Group registry | PLOS ONE
Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry | PLOS ONE

Frontiers | An Immune-Clinical Prognostic Index (ICPI) for Patients With De  Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy
Frontiers | An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy

Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic  model that is superior to existing risk scores for predicting  progression‐free survival and early treatment failure after frontline  immunochemotherapy - Mir - 2020 -
Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression‐free survival and early treatment failure after frontline immunochemotherapy - Mir - 2020 -

PFS and OS based on FLIPI and FLIPI2 | Download Table
PFS and OS based on FLIPI and FLIPI2 | Download Table

FLIPI and PRIMA-PI risk factors | Download Scientific Diagram
FLIPI and PRIMA-PI risk factors | Download Scientific Diagram

A clinico-molecular predictor identifies follicular lymphoma patients at  risk of early transformation after first-line immunotherapy | Haematologica
A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy | Haematologica

Clinical and Biological Prognostic Factors in Follicular Lymphoma -  Hematology/Oncology Clinics
Clinical and Biological Prognostic Factors in Follicular Lymphoma - Hematology/Oncology Clinics

Validation, revision and extension of the Follicular Lymphoma International  Prognostic Index (FLIPI) in a population-based setting - Annals of Oncology
Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting - Annals of Oncology

Integration of gene mutations in risk prognostication for patients  receiving first-line immunochemotherapy for follicular lymphoma: a  retrospective analysis of a prospective clinical trial and validation in a  population-based registry - The Lancet
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry - The Lancet

PDF) {"__content__"=>"A simplified scoring system in follicular lymphoma  treated initially with immunochemotherapy.", "i"=>{"__content__"=>"de  novo"}} | Alain Delmer - Academia.edu
PDF) {"__content__"=>"A simplified scoring system in follicular lymphoma treated initially with immunochemotherapy.", "i"=>{"__content__"=>"de novo"}} | Alain Delmer - Academia.edu

A simplified scoring system in de novo follicular lymphoma treated  initially with immunochemotherapy - ScienceDirect
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy - ScienceDirect

Follicular Lymphoma: Practice Essentials, Etiology and Pathophysiology,  Epidemiology
Follicular Lymphoma: Practice Essentials, Etiology and Pathophysiology, Epidemiology

Outcome and risk of lymphoma progression according a risk groups as... |  Download Scientific Diagram
Outcome and risk of lymphoma progression according a risk groups as... | Download Scientific Diagram

Follicular — HaemBase
Follicular — HaemBase

A simplified scoring system in de novo follicular lymphoma treated  initially with immunochemotherapy - ScienceDirect
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy - ScienceDirect

Outcome Comparisons, Stratified by FLIPI Score | Download Table
Outcome Comparisons, Stratified by FLIPI Score | Download Table

FLIPI2 | Mike's Chemotherapy for Follicular Cancer Experience
FLIPI2 | Mike's Chemotherapy for Follicular Cancer Experience

Follicular Lymphoma International Prognostic Index (FLIPI) and FLIPI-2 -  thehematologist.org
Follicular Lymphoma International Prognostic Index (FLIPI) and FLIPI-2 - thehematologist.org

Diagnostics | Free Full-Text | Imaging of Early Response to Predict  Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma  with Iodine-131-Rituximab Radioimmunotherapy
Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy

Follicular Lymphoma International Prognostic Index 2: A New Prognostic  Index for Follicular Lymphoma Developed by the International Follicular  Lymphoma Prognostic Factor Project | Journal of Clinical Oncology
Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project | Journal of Clinical Oncology

Diagnostics | Free Full-Text | Imaging of Early Response to Predict  Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma  with Iodine-131-Rituximab Radioimmunotherapy
Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy

Workshop With the Experts: Overcoming Barriers to Optimal Treatment of Non-Hodgkin's  Lymphoma Jointly sponsored by Annenberg Center for Health Sciences. - ppt  download
Workshop With the Experts: Overcoming Barriers to Optimal Treatment of Non-Hodgkin's Lymphoma Jointly sponsored by Annenberg Center for Health Sciences. - ppt download